(Q46474595)

22 December 2017

title

Nonconvulsive status epilepticus on treatment with levetiracetam (English)

1 reference

22 December 2017

1 reference

Ramin Atefy

1

1 reference

22 December 2017

Barbara Tettenborn

series ordinal

2

1 reference

22 December 2017

publication date

1 June 2005

1 reference

22 December 2017

published in

Epilepsy Behavior

1 reference

22 December 2017

volume

6

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

613-616

1 reference

22 December 2017

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

Seizure-inducing effects of antiepileptic drugs: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

Nonconvulsive status epilepticus in two patients receiving tiagabine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

Antiepileptic drugs as a cause of worsening seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.03.015

10.1016/J.YEBEH.2005.03.015

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017